publication date: Oct. 19, 2018
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.
A year after starting his job as NCI director, Ned Sharpless is reviewing the entire spectrum of NCI research in an effort to focus on areas where the institute plays a key role.
The question of what it would take to get an NCI designation is especially relevant at West Virginia University, one of a growing number of institutions that have embarked upon the path of seeking this distinction.
Reports published annually by the appropriations committees do not rank high in the hierarchy of legislative documents.
The National Academy of Medicine announced the election of regular members and international members during its annual meeting.
- Count Me In pioneers new model in patient-partnered research
- Roswell Park gets over $6M in Moonshot funds to lead immuno-oncology data management resource
- MSK’s Michel Sadelain wins Pasteur-Weizmann/Servier Prize
- Biden, Charpentier, Doudna, Eng, and Thun win ACS Medal of Honor
- Chartbook illustrates inequities in cancer prevention, treatment and survivorship
- NIH memorial service for Alan Rabson scheduled for Oct. 30
- Keytruda-Inlyta combination improved OS and PFS in front line for advanced, metastatic RCC
- Skin creams safe to use before radiation therapy
- Automated system identifies dense tissue in mammograms
- 150-year-old drug might improve radiation therapy
- Myriad’s test receives FDA approval as companion diagnostic for Pfizer’s Talzenna
- FDA publishes guidance on MRD as a biomarker
- Huge variations between countries in time for reimbursement decisions on new cancer drugs
- AbbVie’s sNDA accepted for priority review for Imbruvica in combination with Gazyva for previously untreated CLL
- The Parker Institute, Xyphos Biosciences developing universal programmable CAR-T cells
- PanTher Therapeutics, MD Anderson collaborate on pancreatic cancer treatment